Sonic Incytes
2 known investors
Sonic Incytes makes Velacur ONE, a point-of-care ultrasound elastography device that measures liver elasticity and attenuation using AI-guided multi-frequency shear waves to assess chronic liver diseases such as MASLD and MASH. The device is designed for use in-office by trained medical professionals and is validated against invasive and non-invasive reference standards like biopsy and MRE/MRI-PDFF.